
Sign up to save your podcasts
Or


Johnson & Johnson posts strong 2nd-quarter results and raises guidance for the full fiscal year. Philip Morris has a mixed 2nd-quarter and gets questions about its recent acquisition. Sarah Gentry and Connor Allen analyze those stories, pick out highlights from Netflix’s most recent results, and share why Blue Bird Corp. and DermTech are on their watchlists.
Looking for even more stocks to put on your watchlist? Get 50% off our Stock Advisor service by going to http://StockIdeas.fool.com.
By The Motley Fool4.7
16041,604 ratings
Johnson & Johnson posts strong 2nd-quarter results and raises guidance for the full fiscal year. Philip Morris has a mixed 2nd-quarter and gets questions about its recent acquisition. Sarah Gentry and Connor Allen analyze those stories, pick out highlights from Netflix’s most recent results, and share why Blue Bird Corp. and DermTech are on their watchlists.
Looking for even more stocks to put on your watchlist? Get 50% off our Stock Advisor service by going to http://StockIdeas.fool.com.

3,216 Listeners

1,497 Listeners

806 Listeners

945 Listeners

523 Listeners

1,170 Listeners

2,177 Listeners

825 Listeners

1,403 Listeners

1,039 Listeners

9,629 Listeners

195 Listeners

815 Listeners

81 Listeners

569 Listeners

993 Listeners

41 Listeners